Myasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms
Top Cited Papers
- 1 August 2014
- journal article
- review article
- Published by Elsevier BV in Journal of Autoimmunity
- Vol. 52, 90-100
- https://doi.org/10.1016/j.jaut.2013.12.011
Abstract
No abstract availableKeywords
Funding Information
- 7th Framework Programme of the European Union FIGHT-MG (242210)
- Inserm
- Institute of Myology
This publication has 134 references indexed in Scilit:
- Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritisAnnals Of The Rheumatic Diseases, 2011
- Polyubiquitin binding to ABIN1 is required to prevent autoimmunityThe Journal of Experimental Medicine, 2011
- Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseasesNature Reviews Immunology, 2010
- A systematic review of population based epidemiological studies in Myasthenia GravisBMC Neurology, 2010
- Epstein-Barr virus (EBV)–encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3The Journal of Experimental Medicine, 2009
- Autoimmune myasthenia gravis: emerging clinical and biological heterogeneityThe Lancet Neurology, 2009
- Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSKCell, 2008
- IgG1 antibodies to acetylcholine receptors in ‘seronegative’ myasthenia gravis†Brain, 2008
- Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?Nature Reviews Genetics, 2008
- The Receptor Tyrosine Kinase MuSK Is Required for Neuromuscular Junction Formation In VivoCell, 1996